Duchenne cardiomyopathy: targeting ROS and NOX4 as a promising therapeutic strategy

.

Source: Expert Opinion on Therapeutic Targets - March 23, 2023 Category: Drugs & Pharmacology Authors: Maurilio Sampaolesi Stefan Janssens Robin Duelen Source Type: research